openPR Logo
Press release

Hypertension Drugs Market of ME & A Market 2022 Top Players - Sanofi, Gilead, Abbott, Novartis

10-28-2017 01:27 PM CET | Health & Medicine

Press release from: Market Research Future

/ PR Agency: +1 646 845 9312
Hypertension Drugs Market of ME & A Market 2022 Top Players -

Hypertension Drugs Market of Middle-East and Africa is growing moderately. Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys. Hypertension affects four out of ten adults in Middle East and Africa region. Over 1.5 million deaths occurs due to hypertension in Middle East and Africa.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2636 .

Middle-East and Africa Hypertension Drugs Market is growing moderately. The market is growing at the CAGR of 3.1% and expected to reach to US$ 5.31 billion by 2022.

Countries in Middle East and Africa bear a heavy burden from hypertension diagnosis and treatment. Huge funding in R&D and various initiatives by government are driving the growth for Hypertension Drugs Market in Middle East and Africa.

Regional Analysis of Middle-East and Africa Hypertension Drugs Market:

On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Hypertension Drugs during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market. Considering the Middle-East and Africa Hypertension Drugs Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Hypertension Drugs. Moreover Saudi Arabia market is also growing and second largest market for Hypertension Drugs.

Market Segments:

On the basis of type which comprise Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, Calcium channel blockers, Renin inhibitors, Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators, Aldosterone antagonists, and others.

Browse Report @ https://www.marketresearchfuture.com/reports/hypertension-drugs-market-2636 .

Study objectives of Middle-East and Africa Hypertension Drugs Market:

To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Hypertension Drugs Market.

To provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the Middle-East and Africa Hypertension Drugs Market

To analyze the Middle-East and Africa Hypertension Drugs Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries- Middle East & Africa.

To provide country level analysis of the market with respect to the current market size and future prospective

To provide country level analysis of the market for segments by type and its sub-segments.

To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

Table of Content:

1. Report Prologue
2. Introduction
3. Research Methodology
4. Market Dynamics
5. Market Factor Analysis
6. Middle-East and Africa Hypertension Drugs Market by Type
7. Middle-East and Africa Hypertension Drugs Market by Region

Get Discount @ https://www.marketresearchfuture.com/check-discount/2636 .

Competitors for Middle-East and Africa Hypertension Drugs Market:

Abbott (US), Johnson & Johnson Services, Inc. (US), Novartis (Switzerland), GlaxoSmithKline plc (UK), AstraZeneca (UK), Bayer AG (Germany), Pfizer Inc.(US), Merck & Co., Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US)

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for , regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hypertension Drugs Market of ME & A Market 2022 Top Players - Sanofi, Gilead, Abbott, Novartis here

News-ID: 791387 • Views:

More Releases from Market Research Future

Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating and Coastal Activities
Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating …
As per the latest analysis by Market Research Future, the Small Boats Market Size was estimated at 17.12 (USD Billion) in 2024. The Small Boats Market Industry is expected to grow from 17.88 (USD Billion) in 2025 to 26.41 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.43% during the forecast period (2025 - 2034). The global small boat industry is witnessing significant growth, driven
Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Redefine Vehicle Aesthetics and Functionality
Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Rede …
As per the latest analysis by Market Research Future, the Automotive Trim Market Size was estimated at 140.30 (USD Billion) in 2024. The Automotive Trim Market Industry is expected to grow from 144.87 (USD Billion) in 2025 to 193.22 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.25% during the forecast period (2025 - 2034). The automotive industry is witnessing a significant transformation in vehicle
Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next-Generation Vehicles | Robert Bosch Gmbh, Technoton
Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next- …
As per the latest analysis by Market Research Future, Automotive Fuel Level Sensor Market Size was valued at USD 5,788.04 million in 2024. The Automotive Fuel Level Sensor market industry is projected to grow from USD 6,008.32 million in 2025 to USD 9,201.90 million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.35% during the forecast period (2024 - 2035). With the global automotive industry focused on precision,
Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructure Evolve | Market Growth with 15.62% CAGR
Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructu …
As per the latest analysis by Market Research Future, the Valet Parking Technology Market Size was estimated at 1.41 (USD Billion) in 2024. The Valet Parking Technology Market Industry is expected to grow from 1.63 (USD Billion) in 2025 to 6.01 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 15.62% during the forecast period (2025 - 2034). Valet parking technology is emerging as a transformative

All 5 Releases


More Releases for Hypertension

Hypertension Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hypertension Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hypertension pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Hypertension Pipeline Report • DelveInsight's Hypertension
Hypertension Drugs Market - Breaking the Pressure: Hypertension Drugs Redefining …
Newark, New Castle, USA: The "Hypertension Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Hypertension Drugs Market: https://www.growthplusreports.com/report/hypertension-drugs-market/8760 This latest report researches the industry structure, sales, revenue,
Hypertension Management Devices Market: Rise in Prevalence of Resistant Hyperten …
Market Analysis and Insights of Hypertension Management Devices Market Hypertension Management Devices Market to account USD 9.50 billion and growing at a CAGR of 7.27% by 2032. Although there are still numerous variations available, the major market players are currently developing and testing clinical versions of hypertension treatment devices. Due to the lack of available effective medications, these medical devices are being created with the primary goal of managing cardiovascular illnesses
Anti-hypertension - Drug Pipeline Landscape, 2022
Hypertension also known as high blood pressure is a condition where the force of blood pushing against the arterial walls of heart is consistently higher than the normal. Hypertension can be identified as primary/essential (without a known cause such as age, genetics, sedentary lifestyle, alcohol consumption, high sodium intake etc.) and secondary (due to an underlying condition as its cause such as congenital heart defects, kidney diseases, endocrinal issues, side
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017. High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension